Siemens Healthineers expects FY2027 revenue growth of 4%-5%
Nov 5 - Medical technology company Siemens Healthineers SHLG.DE issued its fiscal 2027 outlook on Thursday after reporting fourth-quarter results as weakness in China continued to weigh on its diagnostics business.
The company expects fiscal 2027 comparable revenue growth of 4%-5% and adjusted basic earnings per share of 2.20 euros ($2.48) to 2.40 euros ($2.70).
Fourth-quarter adjusted EBIT fell 2.0% to 1.077 billion euros from 1.098 billion euros a year earlier
Fourth-quarter revenue rose 7.3% to 6.784 billion euros from 6.322 billion euros a year earlier
Fourth-quarter diagnostics revenue fell 4.2% on a comparable basis to 1.067 billion euros
Weakness in China remained a challenge, with diagnostics revenue in the region hurt by structural changes in the market environment
China accounts for about 10% of group revenue and is Siemens Healthineers' second-largest market after the US
The German company will change its name to Healthineers as part of its planned spin-off from Siemens, which shareholders are due to vote on in February 2027
($1 = 0.8880 euros)